Involvement of hydrogen sulfide and homocysteine transsulfuration pathway in the progression of kidney fibrosis after ureteral obstruction

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1832, Issue 12, 2013, Pages 1989-1997

  Jung, Kyong Jin ^a   Jang, Hee Seong ^a   Kim, Jee In ^a   Han, Sang Jun ^a   Park, Jeen Woo ^b   Park, Kwon Moo ^a  

^a Kyungpook National University School of Medicine   (South Korea)

^b Kyungpook National University   (South Korea)

Author keywords

Cystathionine synthase; Fibrosis; Hydrogen sulfide; NF B; Oxidative stress; TGF

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; CATALASE; COPPER ZINC SUPEROXIDE DISMUTASE; CYSTATHIONINE BETA SYNTHASE; CYSTATHIONINE GAMMA LYASE; GLUTATHIONE; GLUTATHIONE DISULFIDE; HOMOCYSTEINE; HYDROGEN SULFIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MANGANESE SUPEROXIDE DISMUTASE; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DISEASE COURSE; KIDNEY FIBROSIS; LIPID PEROXIDATION; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; URETER OBSTRUCTION;

EID: 84882749713     PISSN: 09254439     EISSN: 1879260X     Source Type: Journal    
DOI: 10.1016/j.bbadis.2013.06.015     Document Type: Article

References (59)

1. Banerjee R. Hydrogen sulfide: redox metabolism and signaling. Antioxid. Redox Signal. 2011, 15:339-341.
2. Hosoki R., Matsuki N., Kimura H. The possible role of hydrogen sulfide as an endogenous smooth muscle relaxant in synergy with nitric oxide. Biochem. Biophys. Res. Commun. 1997, 237:527-531.
3. 2S production in murine tissues. Antioxid. Redox Signal. 2009, 15:363-372.
4. Fiorucci S., Distrutti E., Cirino G., Wallace J.L. The emerging roles of hydrogen sulfide in the gastrointestinal tract and liver. Gastroenterology 2006, 131:259-271.
5. Kimura H. Hydrogen sulfide: its production, release and functions. Amino Acids 2012, 41:113-121.
6. Szabo C. Hydrogen sulphide and its therapeutic potential. Nat. Rev. Drug Discov. 2007, 6:917-935.
7. 2S be the third endogenous gaseous transmitter?. FASEB J. 2002, 16:1792-1798.
8. Chevalier R.L., Thornhill B.A., Forbes M.S., Kiley S.C. Mechanisms of renal injury and progression of renal disease in congenital obstructive nephropathy. Pediatr. Nephrol. 2010, 25:687-697.
9. Klahr S. New insights into the consequences and mechanisms of renal impairment in obstructive nephropathy. Am. J. Kidney Dis. 1991, 18:689-699.
10. 2S)-producing enzymes and capacity in chronic kidney disease. Nephrol. Dial. Transplant. 2012, 27:498-504.
11. Blom H.J., De Vriese A.S. Why are homocysteine levels increased in kidney failure? A metabolic approach. J. Lab. Clin. Med. 2002, 139:262-268.
12. Guttormsen A.B., Ueland P.M., Svarstad E., Refsum H. Kinetic basis of hyperhomocysteinemia in patients with chronic renal failure. Kidney Int. 1997, 52:495-502.
13. Perna A.F., Luciano M.G., Ingrosso D., Pulzella P., Sepe I., Lanza D., Violetti E., Capasso R., Lombardi C., De Santo N.G. Hydrogen sulphide-generating pathways in haemodialysis patients: a study on relevant metabolites and transcriptional regulation of genes encoding for key enzymes. Nephrol. Dial. Transplant. 2009, 24:3756-3763.
14. Wilcken D.E., Gupta V.J. Sulphur containing amino acids in chronic renal failure with particular reference to homocysteine and cysteine-homocysteine mixed disulphide. Eur. J. Clin. Invest. 1979, 9:301-307.
15. Kim J., Kim D.S., Park M.J., Cho H.J., Zervos A.S., Bonventre J.V., Park K.M. Omi/HtrA2 protease is associated with tubular cell apoptosis and fibrosis induced by unilateral ureteral obstruction. Am. J. Physiol. Renal Physiol. 2010, 298:F1332-F1340.
16. Kimura Y., Goto Y., Kimura H. Hydrogen sulfide increases glutathione production and suppresses oxidative stress in mitochondria. Antioxid. Redox Signal. 2010, 12:1-13.
17. Ishigami M., Hiraki K., Umemura K., Ogasawara Y., Ishii K., Kimura H. A source of hydrogen sulfide and a mechanism of its release in the brain. Antioxid. Redox Signal. 2009, 11:205-214.
18. Dombkowski R.A., Russell M.J., Olson K.R. Hydrogen sulfide as an endogenous regulator of vascular smooth muscle tone in trout. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2004, 286:R678-R685.
19. Webb G.D., Lim L.H., Oh V.M., Yeo S.B., Cheong Y.P., Ali M.Y., El Oakley R., Lee C.N., Wong P.S., Caleb M.G., Salto-Tellez M., Bhatia M., Chan E.S., Taylor E.A., Moore P.K. Contractile and vasorelaxant effects of hydrogen sulfide and its biosynthesis in the human internal mammary artery. J. Pharmacol. Exp. Ther. 2008, 324:876-882.
20. Li L., Moore P.K. Putative biological roles of hydrogen sulfide in health and disease: a breath of not so fresh air?. Trends Pharmacol. Sci. 2008, 29:84-90.
21. Cho M.H., Jung K.J., Jang H.S., Kim J.I., Park K.M. Orchiectomy attenuates kidney fibrosis after ureteral obstruction by reduction of oxidative stress in mice. Am. J. Nephrol. 2012, 35:7-16.
22. Jang H.S., Kim J.I., Kim J., Na Y.K., Park J.W., Park K.M. Bone marrow derived cells and reactive oxygen species in hypertrophy of contralateral kidney of transient unilateral renal ischemia-induced mouse. Free Radic. Res. 2012, 46:903-911.
23. Daugherty A., Rateri D., Hong L., Balakrishnan A. Measuring blood pressure in mice using volume pressure recording, a tail-cuff method. J. Vis. Exp. 2009, 27:1291-1292.
24. Xu Z., Prathapasinghe G., Wu N., Hwang S.Y., Siow Y.L., K.O. Ischemia-reperfusion reduces cystathionine-beta-synthase-mediated hydrogen sulfide generation in the kidney. Am. J. Physiol. Renal Physiol. 2009, 297:F27-F35.
25. Sen U., Basu P., Abe O.A., Givvimani S., Tyagi N., Metreveli N., Shah K.S., Passmore J.C., Tyagi S.C. Hydrogen sulfide ameliorates hyperhomocysteinemia-associated chronic renal failure. Am. J. Physiol. Renal Physiol. 2009, 297:F410-F419.
26. Kim J., Seok Y.M., Jung K.J., Park K.M. Reactive oxygen species/oxidative stress contributes to progression of kidney fibrosis following transient ischemic injury in mice. Am. J. Physiol. Renal Physiol. 2009, 297:F461-F470.
27. Buege J.A., Aust S.D. Microsomal lipid peroxidation. Methods Enzymol. 1978, 52:302-310.
28. Akerboom T.P., Sies H. Assay of glutathione, glutathione disulfide, and glutathione mixed disulfides in biological samples. Methods Enzymol. 1981, 77:373-382.
29. Anderson M.E. Determination of glutathione and glutathione disulfide in biological samples. Methods Enzymol. 1985, 113:548-555.
30. Kim J., Kim K.Y., Jang H.S., Yoshida T., Tsuchiya K., Nitta K., Park J.W., Bonventre J.V., Park K.M. Role of cytosolic NADP+-dependent isocitrate dehydrogenase in ischemia-reperfusion injury in mouse kidney. Am. J. Physiol. 2009, 296:F622-F633.
31. Lee S.M., Koh H.J., Park D.C., Song B.J., Huh T.L., Park J.W. Cytosolic NADP(+)-dependent isocitrate dehydrogenase status modulates oxidative damage to cells. Free Radic. Biol. Med. 2002, 32:1185-1196.
32. Jang H.S., Kim J., Kim K.Y., Kim J.I., Cho M.H., Park K.M. Previous ischemia and reperfusion injury results in resistance of the kidney against subsequent ischemia and reperfusion insult in mice; a role for the Akt signal pathway. Nephrol. Dial. Transplant. 2012, 27:3762-3770.
33. Kim J., Kim J.I., Na Y.K., Park K.M. Intra-renal slow cell-cycle cells contribute to the restoration of kidney tubules injured by ischemia/reperfusion. Anat. Cell Biol. 2011, 44:186-193.
34. Jang H.S., Kim J.I., Jung K.J., Kim J., Han K.H., Park K.M. Bone marrow-derived cells play a major role in kidney fibrosis via proliferation and differentiation in the infiltrated site. Biochim. Biophys. Acta 2013, 1832:817-825.
35. Nicholson C.K., Calvert J.W. Hydrogen sulfide and ischemia-reperfusion injury. Pharmacol. Res. 2010, 62:289-297.
36. Wu N., Siow Y.L., K.O. Ischemia/reperfusion reduces transcription factor Sp1-mediated cystathionine beta-synthase expression in the kidney. J. Biol. Chem. 2010, 285:18225-18233.
37. Klahr S., Morrissey J. Obstructive nephropathy and renal fibrosis. Am. J. Physiol. Renal Physiol. 2002, 283:F861-F875.
38. Chevalier R.L., Forbes M.S., Thornhill B.A. Ureteral obstruction as a model of renal interstitial fibrosis and obstructive nephropathy. Kidney Int. 2009, 75:1145-1152.
39. Xia M., Chen L., Muh R.W., Li P.L., Li N. Production and actions of hydrogen sulfide, a novel gaseous bioactive substance, in the kidneys. J. Pharmacol. Exp. Ther. 2009, 329:1056-1062.
40. Wu W.P., Chang C.H., Chiu Y.T., Ku C.L., Wen M.C., Shu K.H., Wu M.J. A reduction of unilateral ureteral obstruction-induced renal fibrosis by a therapy combining valsartan with aliskiren. Am. J. Physiol. Renal Physiol. 2010, 299:F929-F941.
41. 2S as a physiologic vasorelaxant: hypertension in mice with deletion of cystathionine gamma-lyase. Science 2008, 322:587-590.
42. Beltowski J. Hypoxia in the renal medulla: implications for hydrogen sulfide signaling. J. Pharmacol. Exp. Ther. 2010, 334:358-363.
43. Geng B., Chang L., Pan C., Qi Y., Zhao J., Pang Y., Du J., Tang C. Endogenous hydrogen sulfide regulation of myocardial injury induced by isoproterenol. Biochem. Biophys. Res. Commun. 2004, 318:756-763.
44. Kimura Y., Kimura H. Hydrogen sulfide protects neurons from oxidative stress. FASEB J. 2004, 18:1165-1167.
45. Calvert J.W., Jha S., Gundewar S., Elrod J.W., Ramachandran A., Pattillo C.B., Kevil C.G., Lefer D.J. Hydrogen sulfide mediates cardioprotection through Nrf2 signaling. Circ. Res. 2009, 105:365-374.
46. Francoleon N.E., Carrington S.J., Fukuto J.M. The reaction of H(2)S with oxidized thiols: generation of persulfides and implications to H(2)S biology. Arch. Biochem. Biophys. 2011, 516:146-153.
47. 2-induced oxidative damage-implications for the treatment of osteoporosis. Free Radic. Biol. Med. 2011, 50:1314-1323.
48. Li L., Rose P., Moore P.K. Hydrogen sulfide and cell signaling. Annu. Rev. Pharmacol. Toxicol. 2011, 51:169-187.
49. Dickhout J.G., Carlisle R.E., Jerome D.E., Mohammed-Ali Z., Jiang H., Yang G., Mani S., Garg S.K., Banerjee R., Kaufman R.J., Maclean K.N., Wang R., Austin R.C. Integrated stress response modulates cellular redox state via induction of cystathionine gamma-lyase: cross-talk between integrated stress response and thiol metabolism. J. Biol. Chem. 2012, 287:7603-7614.
50. Calvert J.W., Coetzee W.A., Lefer D.J. Novel insights into hydrogen sulfide-mediated cytoprotection. Antioxid. Redox Signal. 2011, 12:1203-1217.
51. Oh G.S., Pae H.O., Lee B.S., Kim B.N., Kim J.M., Kim H.R., Jeon S.B., Jeon W.K., Chae H.J., Chung H.T. Hydrogen sulfide inhibits nitric oxide production and nuclear factor-kappaB via heme oxygenase-1 expression in RAW264.7 macrophages stimulated with lipopolysaccharide. Free Radic. Biol. Med. 2006, 41:106-119.
52. Zanardo R.C., Brancaleone V., Distrutti E., Fiorucci S., Cirino G., Wallace J.L. Hydrogen sulfide is an endogenous modulator of leukocyte-mediated inflammation. FASEB J. 2006, 20:2118-2120.
53. Li L., Rossoni G., Sparatore A., Lee L.C., Del Soldato P., Moore P.K. Anti-inflammatory and gastrointestinal effects of a novel diclofenac derivative. Free Radic. Biol. Med. 2007, 42:706-719.
54. Miyajima A., Chen J., Lawrence C., Ledbetter S., Soslow R.A., Stern J., Jha S., Pigato J., Lemer M.L., Poppas D.P., Vaughan E.D., Felsen D. Antibody to transforming growth factor-beta ameliorates tubular apoptosis in unilateral ureteral obstruction. Kidney Int. 2000, 58:2301-2313.
55. Chevalier R.L. Obstructive nephropathy: towards biomarker discovery and gene therapy. Nat. Clin. Pract. Nephrol. 2006, 2:157-168.
56. Inazaki K., Kanamaru Y., Kojima Y., Sueyoshi N., Okumura K., Kaneko K., Yamashiro Y., Ogawa H., Nakao A. Smad3 deficiency attenuates renal fibrosis, inflammation, and apoptosis after unilateral ureteral obstruction. Kidney Int. 2004, 66:597-604.
57. Sato M., Muragaki Y., Saika S., Roberts A.B., Ooshima A. Targeted disruption of TGF-beta1/Smad3 signaling protects against renal tubulointerstitial fibrosis induced by unilateral ureteral obstruction. J. Clin. Invest. 2003, 112:1486-1494.
58. Yuan P., Xue H., Zhou L., Qu L., Li C., Wang Z., Ni J., Yu C., Yao T., Huang Y., Wang R., Lu L. Rescue of mesangial cells from high glucose-induced over-proliferation and extracellular matrix secretion by hydrogen sulfide. Nephrol. Dial. Transplant. 2011, 26:2119-2126.
59. Fang L.P., Lin Q., Tang C.S., Liu X.M. Hydrogen sulfide attenuates epithelial-mesenchymal transition of human alveolar epithelial cells. Pharmacol. Res. 2010, 61:298-305.